Daina Peirce, NP
Pediatrics · Plymouth, MANPI 1164557526
Payments from drug & device makers
Across 40 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$294
- Tris Pharma Inc$107
- Lundbeck LLC$103
- Otsuka America Pharmaceutical, Inc.$83
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
- Sunovion Pharmaceuticals Inc.$69
- plus $105 from 3 others
What the payments were for
- Food & beverage$79494%
- Education$496%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $294 |
| Tris Pharma Inc | 2 | $107 |
| Lundbeck LLC | 6 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $81 |
| Sunovion Pharmaceuticals Inc. | 5 | $69 |
| Supernus Pharmaceuticals, Inc. | 3 | $65 |
| Corium, LLC | 1 | $24 |
| Alkermes, Inc. | 1 | $16 |
How this compares
$843 in reported general payments places this provider in the 85th percentile of 1,444 pediatrics providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $92,904 |
| Adderall XrDextroamphetamine/Amphetamine | 23 | $6,507 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 23 | $2,644 |
| Methylphenidate ErMethylphenidate Hcl | 17 | $1,503 |
| Bupropion XlBupropion Hcl | 33 | $1,102 |
| Duloxetine Hcl | 27 | $994 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 35 | $894 |
| Aripiprazole | 12 | $668 |
| Fluoxetine Hcl | 42 | $524 |
| Quetiapine Fumarate | 19 | $501 |
| Clozapine | 13 | $411 |
| Clonazepam | 35 | $299 |
| Lamotrigine | 21 | $292 |
| Trazodone Hcl | 28 | $219 |
| Methylphenidate Hcl | 13 | $194 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Plymouth
- R EzekowitzBoston$1.4M
- Maureen LeonardBoston$929K
- Andrew SiesennopBoston$827K
- Alison FriedmannBoston$737K
- Takara StanleyBoston$654K
- Jess KaplanBoston$638K
- Brian HamiltonCambridge$328K
- Qian YuanNewton Lower Falls$207K
- Chris ChenPeabody$165K
- Eric MoultonBoston$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.